Clinical Trial Update: Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABT-510 in combination with chemotherapy for non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ABT-510 (ABT-510)

Snippet

Sponsor: Abbott | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED